Publications

Journal Article Ahead of print
Open access — free full text available
Open access
Electronic publication date
June 18, 2026

View on Pubmed.gov 42309488 | View on doi.org 10.1016/j.ijcar... (full text)

Patient profiles and outcomes of chronic total occlusion percutaneous revascularisation in middle- and high-income regions a cross-sectional study from the European Registry of Chronic Total Occlusions (ERCTO).

Search for publications in this journal Int J Cardiol

EURO CTO investigators

Abstract

BACKGROUND

National income level influences the prevalence and outcomes of cardiovascular disease (CVD), with lower-income countries contributing disproportionately to the global CVD burden. Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) requires specialised equipment, increasing procedural costs. However, whether national income level contributes to disparities in managing patients with CTO remains unclear.

OBJECTIVE

To compare the clinical profiles, procedural settings and outcomes of patients undergoing CTO-PCI in middle-income countries (MICs) and high-income countries (HICs).

METHODS

This cross-sectional study included 15,329 patients who underwent CTO-PCI between 2021 and 2023. Data were obtained from the European Registry of Chronic Total Occlusions (ERCTO). Of the 24 enrolling countries, 7 were classified as MICs and 14 as HICs.

RESULTS

Patients in HICs were older (67 ± 10 vs 61 ± 10 years; p < 0.001) and presented with greater CTO complexity (J-CTO score: 2.31 ± 1.25 vs 1.99 ± 1.17; p < 0.001). Conversely, patients in MICs were more likely to have diabetes (35% vs 29%; p < 0.001) and to be active smokers (59% vs 49%; p < 0.001). Patients in MICs had lower use of mechanical cardiac support (0.1% vs 0.8%; p < 0.001), advanced calcific plaque modification devices (1% vs 6.1%; p < 0.001), and intravascular ultrasound (14% vs 25%; p < 0.001). MICs achieved higher procedural success (89.5% vs 90.5%; p = 0.07) but higher mortality compared to HICs (0.6% vs 0.2%; p < 0.001).

CONCLUSION

Among a selected population of patients undergoing CTO-PCI, notable clinical, anatomical, and procedural differences exist between MICs and HICs. These findings highlight the importance of tailoring public health strategies to optimise cardiovascular care across diverse economic settings.

References

No references provided.

Conflict of interest statement

Declaration of competing interest Authors' financial disclosure, relationships with industry or any other conflict of interest are the following: S. A. Pyxaras reports: consulting/speaker/proctorship honoraria from Abiomed, AstraZeneca, Asahi Intecc, Biotronik, Boston Scientific, and Terumo; G. Werner reports speaker honoraria from Abbott, Asahi Intecc, OrbusNeich, Philips, Siemens, and Terumo; K. Mashayekhi reports: consulting/speaker/proctoring honoraria from Abbott, Abiomed, Asahi Intecc, AstraZeneca, Biotronik, Boston Scientific, Cardinal Health, Daiichi Sankyo, Medtronic, OrbusNeich, Shockwave Medical, Teleflex, and Terumo. M. Ayoub reports: consultant/proctor honoraria from Boston Scientific, Teleflex, Asahi Intecc, Cordis, Terumo, and SIS Medical; O. Goktekin reports: consulting/speaker/proctoring honoraria from Boston Scientific, Medtronic, Microport and Asahi Inc.; P. Agostoni reports: consulting honoraria from Abbott, Boston Scientific, Cordis, iVascular, Medtronic, Neovasc, Seven Sons, Teleflex, and Terumo; R.D. Diletti reports: consultant/proctoring honoraria from Asahi Intecc, Terumo, IMDS, Boston Scientific, Teleflex, and Philips; Sudhir Rathore reports: honoraria for speaker and proctoring from Abbott Vascular and Translumina Therapeutics; AR Galassi reported consulting/speaker honoraria from Asahi Intecc and Ivascular. The other authors have no conflicts of interest to declare relevant to this paper's contents. All Authors certify that they have made substantive contributions that justify being named as co-authors of the present manuscript.

MeSH

Specialties

Copyright

Copyright © 2026. Published by Elsevier B.V.